Evidence mapPaperPMID 41476331Full record

ReviewThe American journal of psychiatry2026

The Evolving ADHD Phenotype in the Externalizing Context.

Joel T Nigg

Abstract readReview
In one paragraph

Review in The American journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joel T NiggDepartment of Psychiatry and Center for Mental Health Innovation, Oregon Health and Science University, Portland.

Funding

Person-centered diagnostics and prediction for child dysregulatory psychopathology using novel phenotypesU01MH135970 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$3.9M
NIMH NIH HHS U01 MH135970
6 · The paper itself

Abstract

Attention deficit hyperactivity disorder (ADHD) is a developmental precursor for future conduct and other externalizing problems. Despite its familiarity, research in the past decade suggests that refining the ADHD phenotype will yield dividends for clinical prediction and treatment specification as well as mechanistic discovery and theory. ADHD is a useful category, yet it comprises multiple constitutive traits requiring further specification. The field is now poised to shift to a useful integration of novel dimensional traits into a refined ADHD phenotype. This shift will need to recognize the importance of both the established ADHD symptom dimensions and other trait dimensions to create new presentations, types, or specifiers in the nosology. Clinical issues include the role of sluggish, disengaged cognitive style of inattention with hypoactivity. Dispositional traits related to emotional dysregulation will be key as well; these include negative affect and irritability (anger dysregulation). In the cognitive sphere, along with ongoing work on executive functions and reward discounting, new insights related to cognitive information gain or neural gain (a mechanism by which relevant neural connections strengthen during rapid information uptake and decision making) may explain other cognitive findings and relate to dispositional traits and clinical features. Due to its early gateway role, clinical prediction algorithms to evaluate course of ADHD and advisability of intervention will be valuable. A neurodevelopmental, early origins perspective, including early developmental programming in the prenatal period, is increasingly informing etiological understanding of ADHD. Nonclinical trait measures are seen as early precursors of ADHD, and ADHD is then a precursor of more serious externalizing and other complications later. This view opens new opportunities for risk detection and prevention. Clinical prediction algorithms should benefit from inclusion of low-cost, readily deployable trait measures discussed here, including selected temperament and cognition measures, which appear to enhance predictive power.

Indexed as

Attention Deficit Disorder with HyperactivityPhenotypeChildHumansAttention Deficit Hyperactivity Disorder (ADHD)Neurodevelopmental DisordersNosologyTemperament

Identifiers

PMID41476331
PMCPMC13004639

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.